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The primary diseases that currently plague the in-
dustrialized world are those resulting from cumula-
tive damage over many years, such as cerebrovascu-
lar diseases, heart disease, and cancer. These diseases
would have been unrecognizable to past generations
of Americans, who dealt with acute conditions re-
lated primarily to infectious diseases and malnutri-
tion. Diseases of the late 20th and early 21st century
are brought on by decades of wear-and-tear, poor
lifestyle choices, and a condition commonly referred
to as “stress.” In fact, the programmed physiological
response to our everyday stressors, the stress re-
sponse, has allowed animals to survive extreme and
dangerous acute conditions. However, overwhelming
evidence during the past few decades indicates that
chronic activation of this biological stress response to
nonlife-threatening situations such as traffic jams and
work pressures affects physiological systems like
immunity and is believed to cause or exacerbate
many contemporary physical and psychological ail-
ments. The study of the relationship among the neu-
ral, endocrine, and immune systems, called psycho-
neuroimmunology, is an important piece in
understanding and treating the effects of stress (Ader
& Cohen, 1993; Solomon, 1969). Understanding this
relationship is especially relevant for the immuno-
compromised population infected with HIV. Stress-
related conditions are prominent clinical problems in
HIV-infected individuals and are associated with
acute as well as chronic conditions. It seems that
stress can have a detrimental effect on oral as well as
general health. Oral immunity and health becomes an
important area of study with regard to the HIV-
infected population, because these individuals are
disproportionately affected with opportunistic oral
and esophageal infections.
Psychoneuroimmunology Theory
Psychoneuroimmunology theory proposes that the
reduction of perceived stress (rather than reduction of
the stressors themselves) and increased immunity are
interrelated. This proposition is based on extensive
evidence that there are multidirectional communica-
tion pathways among the neural, endocrine, and im-
mune systems. For example, immune cells have re-
ceptors that are specific to catecholamines released
during sympathetic nervous system (SNS) activation
and other receptors that are specific to corticosteroids
(primarily cortisol) released by the limbic-hypotha-
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lamic-pituitary-adrenal axis (LHPA) (Borboni et al.,
1989; De Souza, Webster, Grigoriadis, & Tracey,
1989). These two pathways, the SNS and LHPA
axes, are the primary drivers for the stress response
and have a profound inhibitory effect on immune
function. Activation of these pathways coincides
with reduced proliferation of lymphocytes during
administration of immunostimulatory phytohemag-
glutinen and concanavalin-A, reduced natural killer
cell number and activity, reduced number and per-
centage of circulating B and T lymphocytes, and
reduced levels of a number of immunoglobulins.
A number of studies support that there is negative
impact of personal and environmental stressors on
general health and immune function in HIV-infected
individuals (Hillhouse & Adler, 1991; Maier,
Watkins, & Fleshner, 1994; O’Leary, 1990). Per-
sonal stressors that are typically identified include the
HIV infection itself, commonly identified markers of
the disease including CD4 cell count and HIV-
RNA viral load, and stage of HIV disease with as-
sociated symptoms. In addition to these personal
stressors, there are environmental stressors that im-
pact the HIV-infected individual that usually are
identified as an increased number of hassles of daily
living and social issues associated with HIV infec-
tion. These interactions hold importance for the HIV-
infected individual dealing with opportunistic oral
infections and other oral diseases. Theoretically, a
reduction in stress should enhance oral immune func-
tion and reduce stress-related oral symptoms of HIV
infection. Based on this general psychoneuroimmu-
nology model, the authors of this report and other
investigators have hypothesized that various types of
stress reduction techniques will reduce the chronic
activation of the stress response, reduce the stress-
induced progression of HIV-associated oral immuno-
suppression, and reduce common oral manifestations
of compromised immune function in HIV-positive
individuals.
Oral Disease Associated With HIV Infection
Several oral conditions are associated with disease
state and are used in staging systems for the diagno-
sis of progression of HIV infection. Further, oral
conditions are often used as inclusion criteria and
therapeutic endpoints in clinical trials of antiretrovi-
ral drug efficacy. These conditions are categorized as
(a) oral fungal infections including oropharyngeal
candidiasis (OPC), the most common infection of the
mouth, (b) bacterial infections such as necrotizing
ulcerative gingivitis and necrotizing ulcerative peri-
dontitis (HIV peridontitis), (c) oral viral infections
such as Herpes simplex and Epstein-Barr viruses, and
(d) oral malignancies such as Kaposi’s sarcoma.
OPC is the most common oral manifestation of
HIV infection, a significant indicator of CD4 num-
bers, a marker for seroconversion illness, and a first
clinical sign of immunosuppression during the pro-
gression of HIV to AIDS (Langlais & Miller, 1998;
Reichert, Gelderblow, Becker, & Kuntz, 1987). A
number of oral conditions suggest HIV infection in
nondiagnosed subjects. These conditions include
OPC, hairy leukoplakia, Kaposi’s sarcoma, and ul-
cerative gingivitis.
Oral viral infection figures prominently in acute
and chronic oral disease with AIDS. Herpes simplex
virus infections usually appear on the lips as herpes
labialis or in the mouth on keratinized epithelium.
Unlike patients with normal immune function, HIV-
infected individuals may have herpetic lesions on
mucosal surfaces such as the tongue (Langlais &
Miller, 1998; Reichert et al., 1987). Recurrent viral
infections are more frequent, more persistent, and
more severe with HIV immunosuppression. Hairy
leukoplakia on the lateral tongue, specific to HIV-
infected people, is associated with Epstein-Barr virus
and immunosuppression (Langlais & Miller;
Reichert et al.).
Lastly, Kaposi’s sarcoma is the most common
cancer associated with HIV infection, presenting as
painful tumors usually found on the hard palate (Lan-
glais & Miller, 1998; Reichert et al., 1987).
Although immune suppression is associated with
each of these HIV-related oral conditions, altered
oral immunity can be divided into changes in the
specific immune system (activation of lymphocytes
in response to contact with particular antigens) or
innate immune system (general protective mecha-
nisms). The physiological mechanisms are quite dif-
ferent for these two immune systems, but both can be
suppressed by HIV infection. These impairments of
immunity at the oral mucosa can contribute to sus-
ceptibility to opportunistic infectious processes. A
number of studies have reported significant changes
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to specific immunity as it affects oral surfaces. HIV
infection commonly alters oral epithelial cell func-
tion and can impair mucosal CD4 T-cell activity. A
result of this impairment is a reduced cytokine se-
cretion during infection. For example, one of the best
described HIV-associated changes in oral immunity
is a decrease in salivary immunoglobulin A (IgA)
levels (Muller, Froland, Hvatum, Radl, &
Brandtzaeg, 1991). Although most studies report a
reduction in salivary IgA levels in HIV-infected in-
dividuals, IgA levels rise in serum samples—a seem-
ing dichotomy that has yet to be explained.
Reductions in innate oral immunity seem to result
primarily from reductions in saliva secretion (Chal-
lacombe & Sweet, 2002). Reduced fluid-producing
salivary gland function is a common pathology as-
sociated with HIV infection and is reported in 6% to
10% of HIV-infected individuals in the United
States. Further, mouth dryness because of reduced
saliva production (xerostomia) is a common clinical
complaint of HIV infection. Because salivary secre-
tion is the vehicle for many nonspecific immune
factors, reduced saliva production may explain the
reported net reductions in many of the innate factors
that protect the oral mucosal surfaces. Xerostomia
often results from a salivary gland disease seen only
with HIV infection identified as diffuse infiltrative
lymphocytosis syndrome. This syndrome is charac-
terized by parotid gland enlargement, CD8 lympho-
cytosis, and lymphocytic interstitial pneumonitis.
Diffuse infiltrative lymphocytosis syndrome is most
prevalent in the United States among HIV-infected
African American men, a population that generally
has a high level of emotional stress.
Stress as a Mediator of Disease Symptomatology
The oral immunosuppression observed in HIV-
infected individuals is representative of a general
deteriorating host immunity. One likely mechanism
for the decreased immune function is a stress-in-
duced increase in the activity of the LHPA axis. This
enhanced activity results in increased serum cortisol
levels. A number of studies indicate that stress-in-
duced neuroendocrine activation facilitates the
switch from Th1 cytokine production to Th2 cyto-
kine production, which is an important step in the
pathogenesis of HIV disease. Therefore, stress
through activation of the LHPA axis, and activation
of the SNS, may increase viral replication and lead to
HIV disease progression. The overall effect of these
changes is a reduction in the robustness of immune
system communication and a decrease in the number
and activity level of immune cells.
The stress-induced inhibition of immune reactivity
to viral challenge has been reported in animal and
human studies (Mcewen et al., 1997). Normally,
infection with an active influenza strain or inactive
virus will elicit an immune response as measured by
levels of antibodies found in the blood or secreted
fluids. However, stress-induced increases in cortisol
can suppress the immune system response to viral
challenge. For example, Glaser, Pearl, KiecoltGlaser,
and Malarkey, (1994) showed that administration of
the hepatitis B vaccine produces a greater antibody
production in medical students who perceive a better
social support network and less overall stress. In
addition to a stress-induced decrease in the immune
response to viral challenge, the reduced immune
function manifests itself in a reduced capacity to
inhibit reactivation of latent viruses during times of
stress. A common example is the recurrence of fever
blisters and other outbreaks in individuals dealing
with stressful situations (Jemmott & Magloire,
1988). Several studies examining the effects of stress
on medical students indicate an increased outbreak of
herpes and high levels of antibody to Epstein-Barr
virus during examination periods (Malarkey, Pearl,
Demers, KiecoltGlaser, & Glaser, 1995; Glaser et al.,
1994). These same responses to stress have been
observed in men going through divorce proceedings.
Specific to stress-related immune responses in the
mouth, several studies have demonstrated a pro-
nounced immunosuppressive effect with corticoste-
roid administration. Steroid therapy has been shown
repeatedly to predispose individuals to OPC and high
oral yeast levels (Schechtman, Archard, & Cox,
1986; Odds & Webster, 1988).
HIV infection is associated with psychological
and social stresses. Changes in medical status or
personal and work relationships can trigger psycho-
logical distress. Psychosocial factors such as life
stressors, social support, and coping styles have been
associated with reduced immune system measures,
increased physical symptoms, and accelerated HIV
disease progression to AIDS (Leserman, 2000). For
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example, Leserman et al. (2000) and Evans et al.
(1997) demonstrated that stressful life events for
HIV-infected individuals are associated with greater
reductions in killer lymphocytes and faster progres-
sion to AIDS. Further, a longitudinal cohort study
found that low CD4 cell counts were related to
high self-reported life stressors and poor coping
styles (Goodkin, Blaney, & Feaster, 1993). In a study
of HIV-infected men (Caumartin, Joseph, &
Gillespie, 1993), a longer survival time was associ-
ated with greater social participation. It has been
hypothesized that elevated cortisol levels mediate the
effects of stress on the immune system and hasten
disease progression. Membrenon, Irony, & Dere
(1987) showed an increased basal cortisol level in
individuals hospitalized with HIV compared with
non-HIV patients. Recently, it has been demonstrated
that cortisol works in synergy with gp120 (a mem-
brane protein that allows binding of the virus with
CD4 lymphocytes) and leads to apoptosis of
CD4 lymphocytes, thus contributing to the immu-
nosuppression associated with HIV infection (Nair,
Mahajan, Hou, Sweet, & Schwartz, 2000).
Although not studied extensively, there is some
information available concerning the effect of stress
and mood on saliva secretion and oral dryness. It has
been estimated that 29% of HIV-infected individuals
receiving medical care in the United States have
reported subjective oral dryness (Younai et al.,
2001). As discussed earlier, salivary secretion plays a
significant role in oral mucosa immunity. Experienc-
ing a stressful life change or taking prescribed med-
ications that mimic SNS activation significantly re-
duces salivary flow and increases subjective oral
dryness (Bergdahl, Bergdahl, & Johansson, 1997;
Locker, 1993). In addition, studies suggest that xe-
rostomia resulting from prescribed medications may
result in part from psychological factors (Locker,
1993). It seems that affect such as depression or
anxiety can also reduce salivary flow and increase
subjective oral dryness (Bergdahl et al., 1997;
Mathew, Weinman, & Claghorn, 1979). One study
examining oral dryness in clinically depressed indi-
viduals showed an increase in saliva production fol-
lowing electroconvulsive therapy (Bolwig, 1972). So
it is fairly clear that stress and affect can play a
significant role in saliva production and subjective
oral dryness and in the resultant reduction in immune
function.
Stress Management and Immune Function
Whereas it seems that the industrialized world is
destined biologically to suffer from stress and its
associated problems, there is good news in that we
have the capacity to control our responses to stress.
Remember, it is the perceived stress rather than the
stressor itself that controls our physiological stress
response. It is generally accepted that managing
stress levels is an important aspect in the treatment of
HIV. A number of studies have shown beneficial
physiological and psychological effects of stress
management therapy in HIV disease (Auberbach,
Oleson, & Soloman, 1992; Eller, 1999b; LaPerriere
et al., 1990). Stress management has been shown to
decrease HIV-related symptoms, increase vigor and
hardiness, and increase CD4 cell number (Auber-
bach et al., 1992; Eller, 1999a; Eller, 1999b). Antoni
et al. (2002) have shown repeatedly the effectiveness
of cognitive behavioral stress management tech-
niques in improving outcomes in HIV-infected indi-
viduals (Ironson et al., 1990; LaPerriere et al.; Antoni
et al.). For example, these investigators showed re-
duced self-reported depressed affect and anxiety in
conjunction with reduced salivary and urinary corti-
sol and increases in natural killer cell and CD4 cell
number. Further, the reduction in salivary cortisol
correlated with the number of relaxation sessions
during the study.
A stress reduction technique that is growing in
popularity and is of interest to the authors is acu-
puncture. A number of studies indicate that acupunc-
ture can enhance immune function or reduce the
immunosuppression associated with trauma, stress,
and infection. Recent studies of acupuncture in
asthma patients showed increased levels of CD3/
CD4 cells, decreased interleukin 6 and interleukin
10, increased in vitro lymphocyte proliferation rate,
and enhanced immunoglobulin levels, compared
with controls (Joos, Schott, Zou, Daniel, & Martin,
2000). Berman and Lundberg (2002) showed that a
9-month regimen of acupuncture reduced plasma
cortisol levels in prison psychiatric patients. In addi-
tion, the patients reported increased perceived auton-
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omy, improved inner harmony, and increased
calmness.
A number of studies suggest that acupuncture can
regulate oral immunological functions and relieve
oral symptoms that are common with HIV infection.
Blom et al. (1992) reported that 12 weeks of acu-
puncture on subjects with severe xerostomia in-
creased salivary flow rates as compared with con-
trols. Further, acupuncture has been shown to
enhance salivary and gingival fluid immunoglobulin
levels in healthy individuals (Yang, Ng, Zeng, &
Kwok, 1989), and reduce salivary IgA in patients
with allergic asthma (Yang, Chen, Zhao, & Wang,
1995). These studies are supported by results from
the authors’ laboratory that indicate a regimen of
stress-reduction acupuncture in HIV-infected indi-
viduals reduces perceived stress levels, increases sal-
ivary IgA levels, reduces salivary cortisol levels, and
reduces the number and size of HIV-related fungal
and bacterial mouth infections.
In summary, it is well established that personal
and environmental stressors can take a serious toll on
the health of HIV-infected individuals. When added
to the immunosuppression associated with infection,
chronic biological stress responses not only affect
general health but also predispose the infected indi-
vidual to opportunistic infections of the mouth and
pharynx at a rate much greater than in the general
population. It stands to reason that stress manage-
ment techniques for the HIV-infected population
would reduce the high incidence of oral morbidity
that causes so much discomfort and exacerbates se-
rious disease conditions. Whether through Western-
ized or traditional Eastern techniques, it is important
for professional caregivers involved with the HIV-
infected population to promote stress management as
a component of a holistic health care approach.
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